skip to Main Content
+44 (0) 20 3828 6228, +44 (0) 20 3816 9524 info@siriusmarketaccess.com
HTA-strategy-services

Evidence reviews are a summary of key evidence relating to a disease indication or treatment. They serve a range of purposes, from being an educational tool allowing clients to gain an in-depth understanding of a disease area, to supporting brand and project strategy development. Evidence reviews can be used to inform both clinical and market access strategy at every stage of the drug development process, and can identify data gaps within the current literature. They can include chapters which cover a broad range of topics such as disease definitions, diagnoses, epidemiology, treatment landscape, key clinical trials, real world evidence, heath-related quality of life, and economic evidence.

SIRIUS Market Access have experience in producing specialist pharma evidence reviews across a broad range of disease areas and therapeutic indications. We work closely with each client to deliver a tailored evidence review, while drawing on our expertise to provide recommendations and strategic insights. Our evidence reviews are targeted to our clients’ specific needs and clearly communicate the most relevant data for our clients’ requirements. Our targeted evidence reviews are highly regarded by our clients and support product development, evidence generation activities, and development of market access strategies.

If you’re interested in working with SIRIUS, please get in touch using the CONTACT page.